Abstract
Restriction enzymes (or restriction endonucleases) are bacterial enzymes capable of cleaving double-stranded DNA. Even though the enzymes are bacterial in origin, because of the universal nature of DNA they can digest DNA from any species, including humans. Importantly, restriction enzymes (REs) carry out this cleavage at specific sites in DNA governed by the sequence context (so-called recognition sequences). Hence, REs are known to be extremely sequence-specific; subtle alterations in the recognition sequence render the sites indigestible. This fact is the basis of their usefulness in clinical research and diagnostics. Table 1 is a list of a few of the common REs showing their sequence specificities. Figure 1 shows the interaction of a RE with DNA. The RE interacts with DNA via multiple hydrogen bonds (typically 10/2-15) plus numerous van der Waals interactions. Only when the RE-DNA complex is tightly bound does the catalytic domain cause DNA cleavage (2).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Horton, J. R., Nastri, H. G., Riggs, P. D., Cheng, X. (1998) Asp34 of PvuII endonuclease is directly involved in DNA minor groove recognition and indirectly involved in catalysis J. Mol. Biol. 284, 1491–1504.
Pingoud, A. and Jeltsch, A. (2001) Structure and function of type II restriction endonucleases. Nucleic Acids Res. 29, 3705–3727.
Brown, T. A. (1990) Gene Cloning, 2nd ed., Chapman & Hall, London.
Roberts, R. J. and Macelis, D. (2001) REBASE: restriction enzymes and methylases. Nucleic Acids Res. 29, 268–269.
Cotton, G. H. (1989) Detection of single base changes in nucleic acids. Biochem. J. 263, 1–10.
Minami, R., Aoyama, N., Honsako, Y., Kasuga, M., Fujimura, T., and Maeda, S. (1997) Codon 201 (arg/gly) polymorphism of DCC (deleted in colorectal cancer) gene in flat and polypoid type colorectal tumours. Dig. Dis. Sci. 42, 2446–2452.
Prosser, J. and Condie, A. (1991) Biallelic Apa I polymorphism of the human p53 gene (TP53). Nuc. Acids. Res. 19, 4799.
Garte, S. (1998) The role of ethnicity in cancer susceptibility gene polymorphisms: example of CYP1A1. Carcinogenesis 19, 1329–1332.
Cohen, J. B. and Levinson, A. D. (1988) A point mutation in the last intron responsible for increased expression and transforming activity of the c-Ha-ras oncogene. Nature 334, 119–124.
Ye, Z. and Parry, J. M. (2002) The CYP17 MspA1 polymorphism and breast cancer risk: a metaanalysis. Mutagenesis 17, 119–126.
Levi, S., Urbano-Ispizua, Gill, R., et al. (1991) Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrating a sensitive polymerase chain reaction technique Cancer Res. 51, 3497–3502.
Ward, R., Hawkins, N., O'Grady, R., et al. (1998) Restriction endonuclease mediated selective polymerase chain reaction. Am. J. Pathol. 153, 373–379.
Jenkins, G. J. S., Suzen, H. S., Sueiro, R. A., and Parry, J. M. (1999) The restriction site mutation (RSM) assay. A review of the methodology development and the current status of the technique. Mutagenesis 14, 439–448.
Jenkins, G. J. S., Morgan, C., Parry, E. M., Baxter, J. N., and Parry J. M. (2001) The detection of mutations induced in vitro in the human p53 gene by a model reactive oxygen species (ROS) employing the restriction site mutation (RSM) assay. Mutat. Res. 498, 135–144.
Jenkins G. J. S., Doak, S. H., Griffiths, A. P., Baxter, J. N., and Parry, J. M. (2003) Early p53 mutations in non-dysplastic Barrett’s tissues detected by the restriction site mutation (RSM) methodology. Br. J. Cancer 88, 1271–1276.
Parry, J. M., Shamsheer, M., and Skibinski, D. (1990) Restriction site mutation analysis, a proposed methodology for the detection and study of DNA base changes following mutagen exposure. Mutagenesis, 5, 209–212.
Jenkins G. J. S., Chalestori, M. H., Song H., and Parry, J. M. (1998) Mutation analysis using the restriction site mutation (RSM) assay. Mutat. Res. 405, 209–220
Perwez Hussain, S. P., Aguilar, F. Amstad, P., and Cerutti, P. (1994) Oxyradical induced mutagenesis of hotspot codons 248 and 249 of the human p53 gene. Oncogene 9, 2277–2281.
Morgan, C., Jenkins, G. J. S., Ashton, T., et al. (2003) The detection of p53 mutations in pre-cancerous gastric tissue using the RSM assay. Br. J. Cancer 89, 1314–1319.
Perwez Hussain, S., Amstad, P., Raja, K., et al. (2000) Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer prone chronic inflammatory disease, Cancer Res. 60, 333–3337.
Ehrlich, M. and Wang, R. H. Y. (1981) 5-Methylcytosine in eukaryotic DNA. Science 212, 1350–1357.
Toyota, M. and Issa, J. P. J. (2000) The role of DNA hypermethylation in human neoplasia. Electrophoresis 21, 329–333.
Fraga, M. E. and Esteller, M. (2002) DNA methylation: a profile of methods and applications Biotechniques 33, 632.
Oakeley, E. J. (1999) DNA methylation analysis: a review of current methodologies. Pharmacol. Ther. 84, 389–400.
Puvvada, M. S., Hartley, J. A., Jenkins, T. C., and Thurston, D. E. (1993) A quantitative assay to measure the relative DNA-binding affinity of pyrrolo[2,1-c][1,4]benzodiazepine (pbd) antitumor antibiotics based on the inhibition of restriction-endonuclease BamHI. Nucleic Acids Res. 21, 3671–3675.
Denissenko, M. F., Venkatachalam, S., Ma, Y. H., and Wani, A. A. (1996) Site-specific induction and repair of benzo[a]pyrene diol epoxide DNA damage in human H-ras protooncogene as revealed by restriction cleavage inhibition Mutation Res. 36, 27–42.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Jenkins, G.J.S. (2005). Restriction Enzymes. In: Walker, J.M., Rapley, R. (eds) Medical Biomethods Handbook. Springer Protocols Handbooks. Humana Press. https://doi.org/10.1385/1-59259-870-6:025
Download citation
DOI: https://doi.org/10.1385/1-59259-870-6:025
Publisher Name: Humana Press
Print ISBN: 978-1-58829-288-9
Online ISBN: 978-1-59259-870-0
eBook Packages: Springer Protocols